OrbiMed’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $145M | Hold |
|
|||||
|
2025
Q1 | $104M | Hold |
|
|||||
|
2024
Q4 | $87.4M | Hold |
|
|||||
|
2024
Q3 | $120M | Sell |
|
|||||
|
2024
Q2 | $78.6M | Hold |
|
|||||
|
2024
Q1 | $94.4M | Hold |
|
|||||
|
2023
Q4 | $50.6M | Hold |
|
|||||
|
2023
Q3 | $34.9M | Buy |
|
|||||
|
2023
Q2 | $58.6M | Hold |
|
|||||
|
2023
Q1 | $56.9M | Hold |
|
|||||
|
2022
Q4 | $74.6M | Hold |
|
|||||
|
2022
Q3 | $46.2K | Hold |
|
|||||
|
2022
Q2 | $37.1K | Hold |
|
|||||
|
2022
Q1 | $30.7M | Hold |
|
|||||
|
2021
Q4 | $58.2M | Hold |
|
|||||
|
2021
Q3 | $87.2M | Hold |
|
|||||
|
2021
Q2 | $270M | Hold |
|
|||||
|
2021
Q1 | $381M | Hold |
|
|||||
|
2020
Q4 | $405M | Buy |
|